全ゲノムシーケンス市場-世界の産業規模、シェア、動向、機会、予測、製品・サービス別、タイプ別、ワークフロー別、用途別、エンドユーザー別、地域別、競合別、2020年～2030年

全ゲノムシーケンス（WGS）の世界市場は、2024年に20億5,000万米ドルと評価され、予測期間中に12.15％のCAGRで成長し、2030年までには40億9,000万米ドルに達すると予測されています。

WGSは、生物の全遺伝子設計図を解析する能力により、ゲノミクス、個別化医療、診断、研究において基盤となるツールとなっています。シーケンス技術の継続的な進歩、スループットの向上、コストの低下により、ヘルスケア、農業、法医学を含む多様な分野でWGSの採用が拡大しています。臨床診断におけるWGSの統合が進み、ゲノミクスへの公的・民間投資が拡大していることが、市場の勢いをさらに促進しています。高コスト、データ管理の複雑さ、規制遵守などの課題は残るものの、AIと機械学習の統合と新たなアプリケーションの出現により、市場の成長軌道は加速すると予想されます。

主要な市場促進要因

遺伝性疾患の有病率の増加

主要な市場課題

全ゲノムシーケンスの高コスト

主要市場動向

ゲノムデータ解析における人工知能と機械学習の統合

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 全ゲノムシーケンス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品・サービス別（機器、消耗品、サービス）
  • タイプ別（大規模全ゲノムシーケンス、小規模全ゲノムシーケンス）
  • ワークフロー別（プレシーケンス、シーケンス、データ分析）
  • 用途別（ヒト全ゲノムシーケンス、植物全ゲノムシーケンス、動物全ゲノムシーケンス、微生物全ゲノムシーケンス）
  • エンドユーザー別（学術・研究機関、病院・診療所、製薬・バイオテクノロジー企業、その他）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米の全ゲノムシーケンス市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の全ゲノムシーケンス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋の全ゲノムシーケンス市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の全ゲノムシーケンス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの全ゲノムシーケンス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の全ゲノムシーケンス市場：SWOT分析

第14章 競合情勢

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies plc.
• Pacific Biosciences of California, Inc.
• BGI
• QIAGEN
• Agilent Technologies, Inc.
• ProPhase Labs, Inc.
• Psomagen, Inc
• Azenta US Inc..

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Whole Genome Sequencing (WGS) Market was valued at USD 2.05 billion in 2024 and is expected to reach USD 4.09 billion by 2030, growing at a CAGR of 12.15% during the forecast period. WGS has become a foundational tool across genomics, personalized medicine, diagnostics, and research, owing to its ability to analyze an organism's entire genetic blueprint. Continuous advancements in sequencing technology, increased throughput, and declining costs are expanding WGS adoption across diverse sectors including healthcare, agriculture, and forensics. The growing integration of WGS in clinical diagnostics and expanding public and private investments in genomics are further driving market momentum. While challenges such as high costs, data management complexity, and regulatory compliance remain, the integration of AI and machine learning, along with the emergence of new applications, is expected to accelerate the market's growth trajectory.

Key Market Drivers

Increasing Prevalence of Genetic Disorders

The rise in genetic disorders globally is a key factor propelling the adoption of whole genome sequencing. Genetic conditions affect approximately 2-5% of live births, with a considerable global impact on childhood morbidity and mortality. With up to 80 million individuals estimated to be living with rare genetic disorders worldwide, the need for comprehensive diagnostic tools is escalating. WGS enables precise identification of genetic mutations, offering superior accuracy compared to traditional diagnostic methods. In countries like India, where nearly one million infants are born annually with genetic disorders-many undiagnosed-the use of WGS allows clinicians to detect conditions early and implement targeted treatments. This ability to provide early diagnosis, personalized care, and improved clinical outcomes positions WGS as a critical solution amid rising genetic health concerns.

Key Market Challenges

High Cost of Whole Genome Sequencing

Although sequencing costs have significantly declined, the overall expense associated with WGS remains a substantial barrier to widespread adoption, especially in low- and middle-income regions. While sequencing a genome can now be achieved for under $1,000, ancillary costs such as data analysis, storage, and advanced computational infrastructure add to the financial burden. Institutions must also invest in trained personnel to interpret complex genomic data. These cost-related challenges can limit access to WGS in smaller hospitals and research facilities, despite its long-term benefits in enhancing healthcare outcomes. This financial barrier continues to restrict the market's accessibility and full-scale integration into routine clinical practices.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning in Genomic Data Analysis

A transformative trend in the WGS market is the growing use of artificial intelligence (AI) and machine learning (ML) for genomic data interpretation. The immense volume of data generated by WGS requires advanced analytics to extract meaningful insights. AI and ML technologies can identify complex patterns, predict mutation effects, and enhance the precision of personalized treatment strategies. These tools are revolutionizing clinical decision-making, enabling faster and more accurate diagnoses, supporting drug discovery, and optimizing research workflows. As AI-driven solutions continue to evolve, they will play a crucial role in scaling the utility of WGS across both clinical and research applications, enhancing efficiency and expanding its real-world impact.

Key Market Players

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies plc.
• Pacific Biosciences of California, Inc.
• BGI
• QIAGEN
• Agilent Technologies, Inc.
• ProPhase Labs, Inc.
• Psomagen, Inc
• Azenta US Inc.

Report Scope:

In this report, the Global Whole Genome Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Whole Genome Sequencing Market, By Product & Service:

• Instruments
• Consumables
• Services

Whole Genome Sequencing Market, By Type:

• Large Whole Genome Sequencing
• Small Whole Genome Sequencing

Whole Genome Sequencing Market, By Workflow:

• Pre-sequencing
• Sequencing
• Data Analysis

Whole Genome Sequencing Market, By Application:

• Human Whole Genome Sequencing
• Plant Whole Genome Sequencing
• Animal Whole Genome Sequencing
• Microbial Whole Genome Sequencing

Whole Genome Sequencing Market, By End User:

• Academic & Research Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

Whole Genome Sequencing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Whole Genome Sequencing Market.

Available Customizations:

Global Whole Genome Sequencing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Whole Genome Sequencing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Service (Instruments, Consumables, Services)
  • 5.2.2. By Type (Large Whole Genome Sequencing, Small Whole Genome Sequencing)
  • 5.2.3. By Workflow (Pre-sequencing, Sequencing, Data Analysis)
  • 5.2.4. By Application (Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing, Microbial Whole Genome Sequencing)
  • 5.2.5. By End User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Whole Genome Sequencing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By Workflow
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Whole Genome Sequencing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Workflow
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Whole Genome Sequencing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Workflow
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Whole Genome Sequencing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Workflow
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Whole Genome Sequencing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By Workflow
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Whole Genome Sequencing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Workflow
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Whole Genome Sequencing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Workflow
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Whole Genome Sequencing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Workflow
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. France Whole Genome Sequencing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Workflow
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Whole Genome Sequencing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Workflow
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia-Pacific Whole Genome Sequencing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By Workflow
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Whole Genome Sequencing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Workflow
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Whole Genome Sequencing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Workflow
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Whole Genome Sequencing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Workflow
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Whole Genome Sequencing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Workflow
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Whole Genome Sequencing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Workflow
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. South America Whole Genome Sequencing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By Workflow
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Whole Genome Sequencing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Workflow
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Whole Genome Sequencing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Workflow
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Whole Genome Sequencing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Workflow
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. Middle East and Africa Whole Genome Sequencing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By Workflow
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Whole Genome Sequencing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Workflow
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Whole Genome Sequencing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Workflow
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Whole Genome Sequencing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Workflow
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Whole Genome Sequencing Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Illumina, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Thermo Fisher Scientific Inc.
• 14.3. Oxford Nanopore Technologies plc.
• 14.4. Pacific Biosciences of California, Inc.
• 14.5. BGI
• 14.6. QIAGEN
• 14.7. Agilent Technologies, Inc.
• 14.8. ProPhase Labs, Inc.
• 14.9. Psomagen, Inc
• 14.10.Azenta US Inc..

15. Strategic Recommendations

16. About Us & Disclaimer